Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2001 2
2004 1
2005 2
2007 1
2011 1
2013 2
2014 1
2015 1
2016 2
2017 2
2018 5
2019 3
2020 5
2021 8
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
Ozone-induced encephalopathy: A novel iatrogenic entity.
Haggiag S, Prosperini L, Stasolla A, Gerace C, Tortorella C, Gasperini C. Haggiag S, et al. Eur J Neurol. 2021 Aug;28(8):2471-2478. doi: 10.1111/ene.14793. Epub 2021 Mar 19. Eur J Neurol. 2021. PMID: 33657263 Review.
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.
Tortorella C, Aiello A, Gasperini C, Agrati C, Castilletti C, Ruggieri S, Meschi S, Matusali G, Colavita F, Farroni C, Cuzzi G, Cimini E, Tartaglia E, Vanini V, Prosperini L, Haggiag S, Galgani S, Quartuccio ME, Salmi A, Repele F, Altera AMG, Cristofanelli F, D'Abramo A, Bevilacqua N, Corpolongo A, Puro V, Vaia F, Capobianchi MR, Ippolito G, Nicastri E, Goletti D; INMI COVID-19 Vaccine Study Group. Tortorella C, et al. Among authors: haggiag s. Neurology. 2022 Feb 1;98(5):e541-e554. doi: 10.1212/WNL.0000000000013108. Epub 2021 Nov 22. Neurology. 2022. PMID: 34810244 Free PMC article.
Painful and involuntary multiple sclerosis.
Bagnato F, Centonze D, Galgani S, Grasso MG, Haggiag S, Strano S. Bagnato F, et al. Among authors: haggiag s. Expert Opin Pharmacother. 2011 Apr;12(5):763-77. doi: 10.1517/14656566.2011.540239. Epub 2011 Feb 17. Expert Opin Pharmacother. 2011. PMID: 21323633 Free PMC article. Review.
Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis.
Prosperini L, Ruggieri S, Haggiag S, Tortorella C, Pozzilli C, Gasperini C. Prosperini L, et al. Among authors: haggiag s. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 9;8(6):e1059. doi: 10.1212/NXI.0000000000001059. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34373345 Free PMC article.
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosis.
Prosperini L, Mancinelli C, Haggiag S, Cordioli C, De Giglio L, De Rossi N, Galgani S, Rasia S, Ruggieri S, Tortorella C, Pozzilli C, Gasperini C. Prosperini L, et al. Among authors: haggiag s. J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):271-277. doi: 10.1136/jnnp-2019-322348. Epub 2020 Jan 23. J Neurol Neurosurg Psychiatry. 2020. PMID: 31974130
Hematopoietic stem cell transplantation for multiple sclerosis.
Burt RK, Cohen B, Rose J, Petersen F, Oyama Y, Stefoski D, Katsamakis G, Carrier E, Kozak T, Muraro PA, Martin R, Hintzen R, Slavin S, Karussis D, Haggiag S, Voltarelli JC, Ellison GW, Jovanovic B, Popat U, McGuirk J, Statkute L, Verda L, Haas J, Arnold R. Burt RK, et al. Among authors: haggiag s. Arch Neurol. 2005 Jun;62(6):860-4. doi: 10.1001/archneur.62.6.860. Arch Neurol. 2005. PMID: 15956156 Review. No abstract available.
39 results